Search

for
Search:

Glossary

Similar Terms

Learn

0 / 0 results

— no results

Research

5 / 30 results

research Impact of Medical Castration on Malignant Arrhythmias in Patients With Prostate Cancer

8 citations , February 2021 in “Journal of the American Heart Association”

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

research Anaphylactic Shock Due to Intravenous Amiodarone; Delusional Parasitosis Associated with Donepezil; Connubial Androgenetic Alopecia; Ciprofloxacin-Induced Torsade de Pointes; Postvaccination Miller Fisher Syndrome; Life-Threatening Anaphylactoid Shock Caused by Recombinant Tissue Plasminogen Activator; Thiazide-Induced Hyponatremia

February 2012 in “Hospital Pharmacy”

research Anti-Anginal and Beta-Adrenoceptor Blocking Drugs

January 1983 in “Side effects of drugs annual”

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

research Used Right, IV Arsenic Is Safe And Effective

1 citations , February 2002 in “Oncology Times”

Intravenous arsenic is safe and effective for treating certain blood cancers.

research Cardiodermatology in the Physician’s Practice

1 citations , January 2019 in “Przegla̧d dermatologiczny”

Skin problems like psoriasis and systemic sclerosis can increase the risk of heart disease, so doctors should watch for heart risks in patients with these conditions.

View more "torsade de pointes" in research →

Community Join

1 / 1 results

community Is there a consensus on RU these days? Pyril turned out to be a bust right?

in Research/Science 17 upvotes 2 years ago

The conversation discusses the effectiveness and safety of hair loss treatments, specifically RU58841 and Pyrilutimide (Pyril), with users sharing that Pyril was no more effective than a placebo and expressing concerns about the safety of RU58841 based on personal experiences and the lack of pharmaceutical interest.